Healthcare Litigation

Healthcare companies rely on Goodwin’s seasoned litigators to aggressively and effectively defend their interests and achieve optimal results including in government investigations, anti-trust matters, reimbursement and intellectual property disputes, and challenges to government agency action.

We have a long track record of success defending clients in investigations related to fraud and abuse and qui tam litigation. When an enforcement action proceeds, we work together with our Government Investigations lawyers to advocate for our clients before the government on a daily basis, responding to investigation requests, negotiating the resolution of enforcement actions and advocating for our clients before a wide range of federal and state agencies.

Our national Securities Litigation group has extensive experience representing healthcare companies at all stages as well as their officers and directors in precedent-setting securities class actions and derivative litigation. We have a deep understanding of the industry issues most often faced by our clients at the pre-clinical, clinical testing, regulatory approval process, post-FDA approval and commercial stages, including communications with FDA, enrollment delays, serious adverse events, sales and marketing practices, billing and reimbursement issues, regulatory inspections and warnings, and supply and manufacturing issues. Our litigators work together with our transactional and regulatory colleagues to advise clients on disclosures when these issues arise in order to proactively mitigate litigation risk and, if litigation is unavoidable, to obtain dismissal at the earliest stages. Our ability to leverage our deep industry knowledge in the courtroom is a key differentiator for our healthcare clients.

Healthcare companies also look to Goodwin to address all their most important competition-related issues. Our antitrust lawyers are deeply immersed in the legal issues at the forefront of antitrust enforcement, with particular experience in issues involving the interaction of antitrust with IP laws and FDA regulations. We have litigated cases and advised clients in this area on matters involving reimbursement claims, licensing, sham litigation, settlement of IP litigation, reverse payments and patent hold-up with standard-setting organizations, among others.

We are well prepared to handle the full range of challenges facing our clients, and frequently represent U.S. and multinational companies and individuals with respect to government and internal corporate investigations, white collar criminal defense, regulatory compliance and related civil litigation, and complex commercial litigation. While we have resolved many of these matters quickly and quietly in advance of litigation and public scrutiny, we are genuine trial lawyers who do not hesitate to try a case when we – and our clients – believe it is the best approach.

Our healthcare litigation team is cross-functional, leveraging the unparalleled sophistication of our supporting practices in the areas of Securities + Shareholder LitigationPrivacy + Cybersecurity, Technology, Executive Compensation, Labor + Employment and Tax. This built-in platform also enables us to handle securities class actions, shareholder derivative litigation and M&A litigation on behalf of our healthcare clients.

Contacts

View Bio

Stuart L. Rosenthal

New York Business Law Leader
Partner
Meet the Team

All Services A-Z